Longboard Pharmaceuticals, Inc. announced the appointment of Dr. Randall Kaye as Chief Medical Officer. Dr. Philip Perera, who has led the clinical development and medical affairs activities since the launch of Longboard, has retired as CMO while remaining with Longboard in an advisory role. Dr. Randall Kaye has over 30 years of experience in the medical field.

Prior to joining Longboard, Dr. Kaye was Chief Medical Officer of Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions. Prior to Neurana, he served as Chief Medical Officer of Click Therapeutics, Inc.